Gabelli & Co Investment Advisers’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-86,200
| Closed | -$890K | – | 268 |
|
|
2023
Q2 | $890K | Hold |
86,200
| – | – | 0.15% | 92 |
|
|
2023
Q1 | $873K | Hold |
86,200
| – | – | 0.17% | 83 |
|
|
2022
Q4 | $858K | Hold |
86,200
| – | – | 0.18% | 88 |
|
|
2022
Q3 | $840K | Hold |
86,200
| – | – | 0.11% | 141 |
|
|
2022
Q2 | $837K | Hold |
86,200
| – | – | 0.11% | 147 |
|
|
2022
Q1 | $836K | Hold |
86,200
| – | – | 0.11% | 150 |
|
|
2021
Q4 | $833K | Hold |
86,200
| – | – | 0.11% | 146 |
|
|
2021
Q3 | $835K | Buy |
+86,200
| New | +$835K | 0.1% | 151 |
|